The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR-16, miR-34c and miR-146a-5p were upregulated in early AD (Braak III and IV), while miR-16, miR-107, miR-128a and miR-146a-5p were downregulated in late AD (Braak VI) compared to HC (Braak I and II) [83]”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“miR-16, miR-34c and miR-146a-5p were upregulated in early AD (Braak III and IV), while miR-16, miR-107, miR-128a and miR-146a-5p were downregulated in late AD (Braak VI) compared to HC (Braak I and II) [83]”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“Interestingly, miR-146a-5p was upregulated in the brains of AD patients compared to HC [50,70,73,74,83], but one study reported that miR-146a-5p was downregulated in the brain of AD patients compared to HC [83].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“miR-146a-5p was upregulated in brains and EVs from plasma of AD patients compared to HC [50,70,73,74,83,87].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“Among these miRNAs, miR-146a-5p [50,70,73,74,83] and miR-132-3p [48,72,80,81,84] were reported to be dysregulated in six independent AD studies, respectively.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“Interestingly, miR-146a-5p was upregulated in the brains of AD patients compared to HC [50,70,73,74,83], but one study reported that miR-146a-5p was downregulated in the brain of AD patients compared to HC [83].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
In the citing paper
“However, some studies reported that miR-146a-5p was downregulated in brains and EVs from whole blood [31,83].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [83]
Citations
Cites
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
SIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity
Michan, S., Li, Y., Chou, M. M.-H., Parrella, E., Ge, H., Long, J. M., Allard, J. S., Lewis, K., Miller, M., Xu, W., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0027-10.2010 · Cited by 541
Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
Welge, V., Fiege, O., Lewczuk, P., Mollenhauer, B., Esselmann, H., Klafki, H.-W., Wolf, S., Trenkwalder, C., Otto, M., Kornhuber, J., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0177-6 · Cited by 152
Research works printed but not linked: 34
- Baraniskin, 2011, Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system, Blood, 117, 3140, 10.1182/blood-2010-09-308684 · DOI
- Baraniskin, 2012, Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma, Neuro Oncol., 14, 29, 10.1093/neuonc/nor169 · DOI
- Cui, 2010, Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease, J. Biol. Chem., 285, 38951, 10.1074/jbc.M110.178848 · DOI · Paper page
- Etheridge, 2011, Extracellular microRNA: a new source of biomarkers, Mutat. Res., 717, 85, 10.1016/j.mrfmmm.2011.03.004 · DOI
- Gallego, 2012, In vivo microRNA detection and quantitation in cerebrospinal fluid, J. Mol. Neurosci., 47, 243, 10.1007/s12031-012-9731-7 · DOI
- Gee, 2011, The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis, Br. J. Cancer, 104, 1168, 10.1038/sj.bjc.6606076 · DOI
- Gordanpour, 2012, MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR), J. Vis. Exp. 63, 10.3791/3874 · DOI
- Hanke, 2010, A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer, Urol. Oncol., 28, 655, 10.1016/j.urolonc.2009.01.027 · DOI
- Hébert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression, Proc. Natl. Acad. Sci. U.S.A, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
- Kai, 2010, MicroRNA assassins: factors that regulate the disappearance of miRNAs, Nat. Struct. Mol. Biol., 17, 5, 10.1038/nsmb.1762 · DOI
- Krol, 2010, Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs, Cell, 141, 618, 10.1016/j.cell.2010.03.039 · DOI · Paper page
- Li, 2011, Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells, Neurosci. Lett., 499, 109, 10.1016/j.neulet.2011.05.044 · DOI · Paper page
- Liu, 2012, MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice, Neurobiol. Aging, 33, 522, 10.1016/j.neurobiolaging.2010.04.034 · DOI
- Lukiw, 2007, Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus, Neuroreport, 18, 297, 10.1097/WNR.0b013e3280148e8b · DOI · Paper page
- Lukiw, 2012, Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA, Neuroreport, 23, 621, 10.1097/WNR.0b013e32835542b0 · DOI · Paper page
- Lukiw, 2007, Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells, J. Inorg. Biochem., 101, 1265, 10.1016/j.jinorgbio.2007.06.004 · DOI
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U.S.A, 105, 10513, 10.1073/pnas.0804549105 · DOI · Paper page
- Nelson, 2010, MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study, J. Alzheimers Dis., 21, 75, 10.3233/JAD-2010-091603 · DOI · Paper page
- Park, 2009, Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, Clin. Cancer Res., 15, 5473, 10.1158/1078-0432.CCR-09-0736 · DOI
- Qureshi, 2013, A novel method for the normalization of microRNA RT-PCR data, BMC Med. Genomics, 6, S14, 10.1186/1755-8794-6-S1-S14 · DOI
- Rissland, 2011, MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes, Mol. Cell, 43, 993, 10.1016/j.molcel.2011.08.021 · DOI
- Schipper, 2007, MicroRNA expression in Alzheimer blood mononuclear cells, Gene Regul. Syst. Biol., 1, 263
- Sethi, 2009, Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex, Neurosci. Lett., 459, 100, 10.1016/j.neulet.2009.04.052 · DOI · Paper page
- Smith, 2011, In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs, J. Neurochem., 116, 240, 10.1111/j.1471-4159.2010.07097.x · DOI · Paper page
- Song, 2012, Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients, Dig. Dis. Sci., 57, 897, 10.1007/s10620-011-1981-7 · DOI
- Teplyuk, 2012, MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity, Neuro Oncol., 14, 689, 10.1093/neuonc/nos074 · DOI
- Turchinovich, 2011, Characterization of extracellular circulating microRNA, Nucleic Acids Res., 39, 7223, 10.1093/nar/gkr254 · DOI · Paper page
- van Rooij, 2007, Control of stress-dependent cardiac growth and gene expression by a microRNA, Science, 316, 575, 10.1126/science.1139089 · DOI
- Wang, 2012, The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?, Med. Hypotheses, 78, 398, 10.1016/j.mehy.2011.11.019 · DOI
- Wang, 2011, Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter, Acta Neuropathol., 121, 193, 10.1007/s00401-010-0756-0 · DOI · Paper page
- Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J. Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
- Yao, 2010, MicroRNA-related cofilin abnormality in Alzheimer's disease, PloS One, 5, e15546, 10.1371/journal.pone.0015546 · DOI
- Zovoilis, 2011, microRNA-34c is a novel target to treat dementias, EMBO J., 30, 4299, 10.1038/emboj.2011.327 · DOI · Paper page
Cited by
Sorted by citations
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
Galimberti, D., Villa, C., Fenoglio, C., Serpente, M., Ghezzi, L., Cioffi, S. M. G., Arighi, A., Fumagalli, G., & Scarpini, E. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140756 · Cited by 222
Wan, Y., Liu, Y., Wang, X., Wu, J., Liu, K., Zhou, J., Liu, L., & Zhang, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121975 · Cited by 182
Epigenetic memory: The Lamarckian brain
Fischer, A. (2014) · The EMBO Journal · doi:10.1002/embj.201387637 · Cited by 107
Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level.
Moon, J., Lee, S.-T., Kong, I. G., Byun, J.-I., Sunwoo, J.-S., Shin, J.-W., Shim, J.-Y., Park, J.-H., Jeon, D., Jung, K.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep20364 · Cited by 69
Metadata
- Authors
- Müller, M., Kuiperij, H. B., Claassen, J. A., Küsters, B., & Verbeek, M. M.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 35
- Issue
- 1
- Pages
- 152-158
- ISSN
- 0197-4580
- Cited by
- 205
- References
- 5
- Language
- en
- Funders
- Center for Translational Molecular Medicine (02N-101)
- Alzheimer Nederland
- Internationale Stichting Alzheimer Onderzoek
- Joint Programming Neurodegenerative Disease
- Alzheimer's Drug Discovery Foundation
- American Alzheimer Association
- Van Alkemade Keuls fonds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2013.07.005
- The paper
- Müller, M., Kuiperij, H. B., Claassen, J. A., Küsters, B., & Verbeek, M. M. (2014). MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2013.07.005
